Literature DB >> 16458769

Smallpox.

Zack S Moore1, Jane F Seward, J Michael Lane.   

Abstract

The WHO declared smallpox eradicated in 1980. However, concern over its potential use by terrorists or in biowarfare has led to striking growth in research related to this much-feared disease. Modern molecular techniques and new animal models are advancing our understanding of smallpox and its interaction with the host immune system. Rapid progress is likewise being made in smallpox laboratory diagnostics, smallpox vaccines, and antiviral medications. WHO and several nations are developing stockpiles of smallpox vaccine for use in the event the disease is reintroduced. National and international public-health agencies have also drawn up plans to help with early detection of and response to a smallpox outbreak. These plans hinge on physicians' ability to recognise the clinical features of smallpox and to distinguish it from other illnesses characterised by rashes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458769     DOI: 10.1016/S0140-6736(06)68143-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity.

Authors:  Dan Huang; Liyou Qiu; Richard Wang; Xioamin Lai; George Du; Probhat Seghal; Yun Shen; Lingyun Shao; Lisa Halliday; Jeff Fortman; Ling Shen; Norman L Letvin; Zheng W Chen
Journal:  J Infect Dis       Date:  2006-11-22       Impact factor: 5.226

Review 2.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

Review 3.  Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.

Authors:  Stephen R Walsh; Raphael Dolin
Journal:  Expert Rev Vaccines       Date:  2011-08       Impact factor: 5.217

Review 4.  Smallpox vaccines for biodefense.

Authors:  Richard B Kennedy; Inna Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

Review 5.  Killing a killer: what next for smallpox?

Authors:  Grant McFadden
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

6.  Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response.

Authors:  Michiko K Oyoshi; Abdallah Elkhal; Lalit Kumar; Jordan E Scott; Suresh Koduru; Rui He; Donald Y M Leung; Michael D Howell; Hans C Oettgen; George F Murphy; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

7.  New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens.

Authors:  Alexandre Borovkov; D Mitch Magee; Andrey Loskutov; Jose A Cano; Cheryl Selinsky; Jason Zsemlye; C Rick Lyons; Kathryn Sykes
Journal:  Virology       Date:  2009-10-02       Impact factor: 3.616

Review 8.  Osteomyelitis variolosa, an issue inherited from the past: case report and systematic review.

Authors:  Jinshuo Tang; Pu Shao; Te Liu; Xinggui Wen; Yeliang Wang; Chenyu Wang; Yachen Peng; Hua Yao; Jianlin Zuo
Journal:  Orphanet J Rare Dis       Date:  2021-08-06       Impact factor: 4.123

9.  Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246.

Authors:  John Huggins; Arthur Goff; Lisa Hensley; Eric Mucker; Josh Shamblin; Carly Wlazlowski; Wendy Johnson; Jennifer Chapman; Tom Larsen; Nancy Twenhafel; Kevin Karem; Inger K Damon; Chelsea M Byrd; Tove' C Bolken; Robert Jordan; Dennis Hruby
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.938

10.  Acute disseminated encephalomyelitis.

Authors:  James J Sejvar
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.